Skin Substitute Application Billing (15271-15278)

How the code set is organised

• 15271 and add-on 15272 — trunk, arms, legs; first 25 sq cm, then each additional 25 sq cm, for wounds under 100 sq cm.
• 15273 and add-on 15274 — the same body areas for total wound surface of 100 sq cm or greater, priced per 100 sq cm.
• 15275 through 15278 — the same two-tier structure for face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet and multiple digits.
• The product itself is reported separately with its own Q-code in the product's own billing units, alongside the application code.

The measurement that drives everything

The size that selects the code is the wound surface area the substitute was applied to, measured after debridement and preparation — not the size of the product opened, and not the pre-debridement measurement. Practices that bill from the graft package size systematically misreport, in whichever direction the packaging happens to run.

Where multiple wounds in the same body-area grouping are treated at one session, their surface areas are summed and the total selects the code. Wounds in different groupings are not summed; each grouping gets its own primary code. Getting the grouping wrong is the most common reason a correctly measured case still pays incorrectly.

Coverage is narrow and product-specific

Skin substitutes are among the most closely reviewed items in the Medicare programme. Coverage articles typically require a documented wound aetiology, a defined period of failed conventional care with dates, adequate vascular supply, absence of active infection, and limits on the number of applications per wound per episode. A product that is not on the payer's covered list is not payable at any documentation standard.

Because acquisition cost is high, an application that fails coverage is not simply unpaid revenue — it is a realised loss. The verification belongs before the graft is opened: product covered by this payer, indication within the article, prior-care requirement satisfied and documented, and the application count for this wound still within limit.

What the operative record must show

• Wound aetiology, duration, and the conventional care already tried with dates and outcomes.
• The measured wound surface area after debridement, in square centimetres, per wound.
• The body area, mapped to the correct code grouping.
• The product name, manufacturer, lot number, and the amount applied and discarded.
• The application number in the treatment sequence for that wound.